Extraordinarily Potent Insulinotropin PACAP : Its Characterization as a Pancreatic Peptide and Action Mechanisms in Islet beta-Cells
极其有效的促胰岛素素 PACAP:其作为胰肽的特性及其在胰岛 β 细胞中的作用机制
基本信息
- 批准号:06454147
- 负责人:
- 金额:$ 4.03万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1994
- 资助国家:日本
- 起止时间:1994 至 1995
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Insulin secretion from pancreatic islets is controlled by peptides as well as by nutrients. Two forms of pituitary adenylate cyclase activating polypeptide (PACAP27 and PACAP38) as low as 10^<-13> M stimulated insulin release from rat islets in a glucosedependent manner. PACAP also increased cytosolic Ca^<2+> concentration ( [Ca^<2+>] _i) in islet beta-cells. A blocker of the L-type Ca^<2+> channel abolished both [Ca^<2+>] _i and insulin responses. PACAP stimulated production of cAMP in islets, and a rise in cAMP mimicked PACAP in increasing [Ca^<2+>] _i in beta-cells. Vasoactive intestinal peptide, a peptide exhibiting high amino acid homology with PACAP,also increased [Ca^<2+>] _i in beta-cells but only at concentrations in the nanomolar range, indicating that PACAP27 is 4 logs more potent. High-affinity type-I PACAP receptor was immunohistochemically localized in islets.We next examined the source and physiological role of PACAP in islets. PACAP-immunoreactivity was demonstrated in pancreatic nerve fibers and islets. PACAP mRNA was detected in islets and in the beta-cell line MIN6. Stimulation of insulin release by high glucose from isolated islets was attenuated by a specific PACAP antiserum. The islet incubation medium with high glucose possessed a capacity, which was neutralized by PACAP antiserum, to increase [Ca^<2+>] _i in beta-cells.The results indicate that PACAP reacts with high affinity PACAP-selective receptor and raises cAMP in beta-cells, which in turn enhances the L-type Ca^<2+> channel activity, increases [Ca^<2+>] _i and consequently potentiates glucose-induced insulin release. PACAP is by far the most potent insulinotropic peptide known. Moreover, PACAP is released from islets and acts on islet beta-cells, thus acting as an autocrine hormone. PACAP,via the autocrine action, amplifies glucose-induced insulin secretion in islets, which is characteristically impaired in non-insulin-dependent diabetes mellitus.
胰岛的胰岛素分泌受肽和营养的控制。两种形式的垂体腺苷酸环化酶激活多肽(PACAP27和PACAP38)低至10^<-13> m,以葡萄糖依赖性的方式刺激了大鼠胰岛释放的胰岛素。 PACAP还增加了胰岛β细胞中的胞质Ca^<2+>浓度([Ca^<2+>] _i)。 L型Ca^<2+>通道的阻滞剂消除了[Ca^<2+>] _i和胰岛素反应。 PACAP刺激了胰岛中的营地的产量,并在β细胞中模仿了[Ca^<2+>] _i的营地的增加。血管活性肠肽是一种与PACAP表现高氨基酸同源性的肽,在β细胞中也增加了[Ca^<2+>] _i,但仅在纳莫尔范围内的浓度下增加,表明PACAP27是4 logs更有效。高亲和力I型PACAP受体在胰岛中被免疫组织化学定位。接下来,我们检查了PACAP在胰岛中的来源和生理作用。胰神经纤维和胰岛中证明了PACAP-免疫反应性。在胰岛和β细胞系MIN6中检测到PACAP mRNA。特定的PACAP抗血清减弱了从分离的胰岛中高葡萄糖刺激胰岛素释放。具有高葡萄糖的胰岛孵育培养基具有由PACAP抗血清中和的能力,可在β细胞中增加[Ca^<2+>] _i。在β细胞又增强了L型Ca^<2+>通道活性的β细胞,增加了[Ca^<2+>] _i,因此增强了葡萄糖诱导的胰岛素释放。 PACAP是迄今为止已知最有效的胰岛素肽。此外,PACAP是从胰岛中释放出来的,并作用于胰岛β细胞,因此充当自分泌激素。 PACAP通过自分泌作用,放大了胰岛中葡萄糖诱导的胰岛素分泌,这在非胰岛素依赖性糖尿病中的特征受损。
项目成果
期刊论文数量(44)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Aizawa, T., Yada, T., Asanuma, N., Sato, Y., Ishihara, F., Hamakawa, N., Yaekura, K.and Hashizume, K.: "Effect of thapsigargin, an intracellular Ca^<2+> pump inhibitor, on inulin release by rat pancreatic B-cells." Life Sciences. 57. 1375-1381 (1995)
Aizawa, T.、Yada, T.、Asanuma, N.、Sato, Y.、Ishihara, F.、Hamakawa, N.、Yaekura, K. 和 Hashizume, K.:“毒胡萝卜素(一种细胞内 Ca^<
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yaekura,K.: "cAMP-signalling pathway acts in selective synergism with glucose or tolbutamide to increase cytosolic Ca^<2+> in rat pancreatic β-cells." Diabetes. 45(in press). (1996)
Yaekura, K.:“cAMP 信号通路与葡萄糖或甲苯磺丁脲选择性协同作用,增加大鼠胰腺 β 细胞中的胞质 Ca^2+”(1996 年出版)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nakahara,K.: "Cytosolic Ca^<2+> increase and cell damage in L6 rat myoblasts by HMG-CoA reductase inhibitors." Biochem.Biophys.Res.Commun.202. 1579-1585 (1994)
Nakahara,K.:“HMG-CoA 还原酶抑制剂导致 L6 大鼠成肌细胞中胞质 Ca^2 增加和细胞损伤。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nakahara, K., Yada, T., Kuriyama, M.and Osame, M.: "Cytosolic Ca^<2+> increase and cell damage in L6 rat myoblasts by HMG-CoA reductase inhibitors." Biochem.Biophys.Res.Commum.202. 1579-1585 (1994)
Nakahara, K.、Yada, T.、Kuriyama, M.和 Osame, M.:“HMG-CoA 还原酶抑制剂导致 L6 大鼠成肌细胞中胞质 Ca^2 增加和细胞损伤。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Fujitani,S.: "Somatostatin and insulin secretion due to common mechanisms by a new hypoglycemic agent,A-4166,in perfused rat pancreas." Metabolism. 45(in press). (1996)
Fujitani,S.:“新型降血糖药 A-4166 在灌注大鼠胰腺中的常见机制导致生长抑素和胰岛素分泌。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YADA Toshihiko其他文献
YADA Toshihiko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YADA Toshihiko', 18)}}的其他基金
Central and organ mechanisms for anti-obesity/diabetes effects of rare sugar allulose
稀有糖阿洛酮糖抗肥胖/糖尿病作用的中枢和器官机制
- 批准号:
19H04045 - 财政年份:2019
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
GLP-1 and insulin synergize to activate vagal afferent nerves leading to central regulation of metabolism, feeding and blood pressure
GLP-1 和胰岛素协同激活迷走神经传入神经,从而实现代谢、进食和血压的中枢调节
- 批准号:
26670453 - 财政年份:2014
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Regulation by Na-K pump of glucose-sensitive NPY neurons and feeding behavior, and its dysfunction in hyperphagia and obesity
Na-K泵对葡萄糖敏感的NPY神经元和摄食行为的调节及其在食欲过多和肥胖中的功能障碍
- 批准号:
24659101 - 财政年份:2012
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Novel function of oxytocin : its anorectic neuronal pathway and(patho) physiological role in regulating feeding
催产素的新功能:其厌食神经元通路和调节摄食的(病理)生理作用
- 批准号:
22659044 - 财政年份:2010
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Ghrelin : its status as a pancreatic hormone, mechanisms by which it regulates insulin release and glucose metabolism, and its application for treating diabetes.
生长素释放肽:其作为胰腺激素的地位、其调节胰岛素释放和葡萄糖代谢的机制及其在治疗糖尿病中的应用。
- 批准号:
20390061 - 财政年份:2008
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Inputs and outputs of NPY and BDNF neurons in the hypothalamus and their implication in feeding and metabolic regulation
下丘脑 NPY 和 BDNF 神经元的输入和输出及其在摄食和代谢调节中的意义
- 批准号:
18390065 - 财政年份:2006
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Regulation by endogenous ghrelin of insulin release, feeding and glucose metabolism
内源性生长素释放肽对胰岛素释放、摄食和葡萄糖代谢的调节
- 批准号:
16390053 - 财政年份:2004
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Novel signaling function of adipocytes
脂肪细胞的新信号传导功能
- 批准号:
15081211 - 财政年份:2003
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Scientific Research on Priority Areas
Regulation by glucose and insulin of the neurons in feeding-regulatory centers and its alteration in obesity and diabetes
葡萄糖和胰岛素对摄食调节中心神经元的调节及其在肥胖和糖尿病中的改变
- 批准号:
12470231 - 财政年份:2000
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Control of glucose metabolism by PACAP : stimulation of insulin secretion and potentiation of insulin action
PACAP 控制葡萄糖代谢:刺激胰岛素分泌并增强胰岛素作用
- 批准号:
09670052 - 财政年份:1997
- 资助金额:
$ 4.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
β-巨噬细胞环路障碍导致胰岛素分泌异常中GPCR所介导的信号机制研究
- 批准号:82330022
- 批准年份:2023
- 资助金额:220 万元
- 项目类别:重点项目
多发性硬化症中铁死亡通过促进胰岛素分泌参与T细胞活化的分子机制研究
- 批准号:32360173
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
胰岛β细胞FIT2-MAG代谢的促胰岛素分泌机制及2型糖尿病干预研究
- 批准号:
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:
一种Zn2+依赖的蜈蚣毒素CAP蛋白促胰岛素分泌的作用分子机制
- 批准号:32371322
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
妊娠期糖尿病胎盘间质细胞促进滋养细胞合成分泌asprosin引起胰岛素抵抗的机制研究
- 批准号:
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:
相似海外基金
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 4.03万 - 项目类别:
Cytoskeleton-mediated regulation of insulin secretion hot spots in pancreatic beta cells
细胞骨架介导的胰腺β细胞胰岛素分泌热点的调节
- 批准号:
10679903 - 财政年份:2023
- 资助金额:
$ 4.03万 - 项目类别:
Interrogating the role of m6A mRNA methylation in the aging of the β-cell and diabetes
探讨 m6A mRNA 甲基化在 β 细胞衰老和糖尿病中的作用
- 批准号:
10644215 - 财政年份:2023
- 资助金额:
$ 4.03万 - 项目类别:
Mentoring Emerging Researchers at CHLA (MERCH-LA)
指导 CHLA (MERCH-LA) 的新兴研究人员
- 批准号:
10797938 - 财政年份:2023
- 资助金额:
$ 4.03万 - 项目类别:
Control of insulin secretion by mitochondrial fusion
通过线粒体融合控制胰岛素分泌
- 批准号:
10753730 - 财政年份:2023
- 资助金额:
$ 4.03万 - 项目类别: